The Cost of Opioid-Related Adverse Drug Events

REFERENCES

• Thomas EJ, Studdert DM, Newhouse JP, Costs of medical injuries in Utah and Colorado. Inquiry. 1999:36:255–264.
   PubMed Web of Science ®Google Scholar
• Bates DW, Cullen DJ, Laird N, Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA. 1995;274:29–34.
   PubMed Web of Science ®Google Scholar
• Bates DW, Spell N, Cullen DJ, The costs of adverse drug events in hospitalized patients. JAMA. 1997;277:307–311.
   PubMed Web of Science ®Google Scholar
• Kane-Gill SL, Jacobi J, Rothschild JR. Adverse drug events in the ICU: risk factors, impact and role of team care. Crit Care Med. 2010;38(6 Suppl):s83–s89
   PubMedGoogle Scholar
• Institute of Medicine, Committee on Identifying and Preventing Medication Errors, Preventing Medication Errors. Washington, DC: National Academies Press; 2007:124–125.
   Google Scholar
• Ford D, Luttrell N. Leadership in patient safety: IV pump auto-programming. Paper presented at Cerner Health Conference; October 2009; Kansas City, MO.
   Google Scholar
• Bohnert AS, Valenstein M, Bair MJ, Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305:1315–1321.
   PubMed Web of Science ®Google Scholar
• Von Korff M, Kolodny A, Deyo RA, Chou R. Long-term opioid therapy reconsidered. Ann Intern Med. 2011;155:325–328.
   PubMed Web of Science ®Google Scholar
• Oderda GM, Evans RS, Lloyd J, Cost of opioid-related adverse drug events in surgical patients. J Pain Symptom Manage. 2003;25:276–283.
   PubMed Web of Science ®Google Scholar
• Moore RA, McQuay HJ. Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomized trials of oral opioids. Arthritis Res Ther. 2005;7:R1046–R1051.
   PubMed Web of Science ®Google Scholar
• Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in the management of chronic non-cancer pain: systematic review of safety and efficacy. Pain. 2004;112:372–380.
   PubMed Web of Science ®Google Scholar
• Devlin JW, Roberts RJ. Pharmacology of commonly used analgesics and sedatives in the ICU: benzodiazepines, propofol and opioids. Anesthesiol Clin. 2011;29:567–585.
   Google Scholar
• Neighbors DM, Bell TJ, Wilson J, Dodd SL. Economic evaluation of the fentanyl transdermal system for the treatment of chronic moderate to severe pain. J Pain Symptom Manage. 2001;21:129–143.
   PubMed Web of Science ®Google Scholar
• Lehmann KA, Radbruch L, Gockel HH, Neighbors D, Nuyts G. Costs of opioid therapy for chronic nonmalignant pain in Germany: an economic model comparing transdermal fentanyl (Durogesic) with controlled-release morphine. Eur J Health Econ. 2002;3:111–119.
   PubMedGoogle Scholar
• Duggan AK. The cost of constipation in morphine patients and the economic possibilities with tramadol. Br J Med Econ. 1995;9:21–29.
   Google Scholar
• Hass B, Lungershausen J, Hertel N, Cost-effectiveness of strong opioids focusing on the long-term effects of opioid-related fractures: a model approach. Eur J Health Econ. 2009;10:309–321.
   PubMed Web of Science ®Google Scholar
• Frei A, Andersen S, Hole P, Jensen NH. A one year health economic model comparing transdermal fentanyl with sustained-release morphine in the treatment of chronic noncancer pain. J Pain Palliat Care Pharmacother. 2003;17:5–26.
   PubMedGoogle Scholar
• Morgan Friedman. The inflation calculator. Available at: http:// www.westegg.com/inflation/infl.cgi. Accessed May 22, 1014.
   Google Scholar
• Kessler ER, Shah M, Gruschkus SK, Raju A. Cost and quality implications of opioid-based postsurgical pain control using administrative claims data from a large health system: opioid-related adverse events and their impact on clinical and economic outcomes. Pharmacotherapy. 2013;33:383–391.
   PubMed Web of Science ®Google Scholar
• Oderda GM, Said Q, Evans RS, Opioid-related adverse drug events in surgical hospitalizations: impact on costs and length of stay. Ann Pharmacother. 2007;41:400–407.
   PubMed Web of Science ®Google Scholar
• Classen DC, Pestonik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA. 1997;277:301–306.
   PubMed Web of Science ®Google Scholar
• Oderda G, Gan T-J, Johnson BH, Robinson SB. Effect of opioid relate advese events on outcomes in selected surgical patients. J Pain Palliat Care Pharmacother. 2013;27:62–70.
   PubMedGoogle Scholar
• Ivanova JI, Birnbaum HG, Yushkina Y, Sorg RA, Reed J, Merchant S. The prevalence of economic impact of prescription opioid-related side effects among patients with chronic noncancer pain. J Opioid Manag. 2013;9:239–254.
   Google Scholar
• Dunlop W, Uhl R, Khan I, Taylor A, Barton G. Quality of life benefits and cost impact of prolonged release oxycodone/naloxone versus prolonged release oxycodone in patients with moderate-to-severe non-malignant pain and opioid-induced constipation: a UK cost-utility analysis. J Med Econ. 2012;15:564–575.
   PubMedGoogle Scholar
• Takemoto ML, Fernandes RA, Almeida GR, Monteiro RD, Colomvini-Neto M, Bertola-Neto A. Health care resource use and costs in opioid-treated patients with and without constipation in Brazil. Value Health. 2011;14(5 Suppl 1):S78–S81.
   Google Scholar
• Hjalte F, Berggren AC, Bergendahl H, Hjortsberg C. The direct and indirect costs of opioid-induced constipation. J Pain Symptom Manage. 2010;40:696–703.
   PubMed Web of Science ®Google Scholar
• Wee B, Adams A, Thompson K, Percival F, Burslem K, Jobanputra M. How much does it cost a specialist palliative care unit to manage constipation in patients receiving opioid therapy? J Pain Symptom Manage. 2010;39:644–654.
   PubMed Web of Science ®Google Scholar
• Iyer S, Davis KL, Candrilli S. Opioid use patterns and health care resource utilization in patients prescribed opioid therapy with and without constipation. Managed Care. 2010;19:44–51.
   Google Scholar
• Kwong WJ, Diels J, Kavanagh S. Costs of gastrointestinal events after outpatient opioid treatment for non-cancer pain. Ann Pharmacother. 2010;44:630–640.
   PubMed Web of Science ®Google Scholar
• Candrilli SD, Davis KL, Iyer S. Impact of constipation on opioid use patterns, health care resource utilization, and costs in cancer patients on opioid therapy. J Pain Palliat Care Pharmacother. 2009;23:231–241.
   PubMedGoogle Scholar
• Flynn TN, Guest JF. Cost of managing constipation among terminally ill cancer patients treated with transdermal fentanyl and 12 hour sustained-release morphine in Canada. J Med Econ. 1999;2:15–32.
   Google Scholar
• Carroll NV, Miederhoff PA, Cox FM, Hirsch JD. Costs incurred by outpatient surgical centers in managing postoperative nausea and vomiting. J Clin Anesth. 1994;6:364–369.
   PubMed Web of Science ®Google Scholar
• Hill RP, Lubarsky DA, Phillips-Bute B, Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo. Anesthesiology. 2000;92:958–967.
   PubMed Web of Science ®Google Scholar
• Suh DC, Kim MS, Chow W, Jang EJ. Use of medications and resources for treatment of nausea, vomiting, or constipation in hospitalized patients treated with analgesics. Clin J Pain. 2011;27:508–517.
   PubMed Web of Science ®Google Scholar
• Asgeirsson T, El-Badawi KI, Mahmood A, Barletta J, Luchtefeld M, Senagore AJ. Postoperative ileus: it costs more than you expect. J Am Coll Surg. 2010;210:228–231.
   PubMed Web of Science ®Google Scholar
• Iyer S1, Saunders WB, Stemkowski S. Economic burden of postoperative ileus associated with colectomy in the United States. J Managed Care Pharm. 2009;15:485–494.
   Google Scholar
• Anastassopoulos KP, Chow W, Tapia CI, Economic study on the impact of side effects in patients taking oxycodone controlled-release for noncancer pain. J Managed Care Pharm. 2012t;18:615–626.
   Google Scholar
• Swegle JM, Logemann C. Management of common opioid-associated adverse effects. Ann Fam Physician. 2006;74: 1347–1354.
   PubMed Web of Science ®Google Scholar
• Voepel-Lewis T, Wagner D, Burke C, Early adjuvant use of nonopioids associated with reduced odds of serious postoperative opioid adverse events and need for rescue in children. Paediatr Anaesth. 2013;23:162–169.
   PubMed Web of Science ®Google Scholar
• Webster L. Efficacy and safety of dual-opioid therapy in acute pain. Pain Med. 2012;13(Suppl 1):s12–s20.
   Google Scholar
• Barr J, Fraser GL, Puntillo K, Clinical practice guidelines for the management of pain, agitation and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41:263–306.
   PubMed Web of Science ®Google Scholar
• Centers for Medicare and Medicaid Services. Hospital consumer assessment of healthcare providers and systems. Available at: http://www.hcahpsonline.org/home.aspx. Accessed May 22, 2014.
   Google Scholar
• McNicol E, Horowicz-Mehler N, Fisk RA, Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain. 2003;4:234–256.
   Google Scholar